Cheng Q - Search Results

1

Innovative utilization of cell membrane-coated nanoparticles in precision cancer therapy.

He Y, Zhang S, She Y, Liu Z, Zhu Y, Cheng Q, Ji X. He Y, et al. Among authors: cheng q. Exploration (Beijing). 2024 Mar 21;4(6):20230164. doi: 10.1002/EXP.20230164. eCollection 2024 Dec. Exploration (Beijing). 2024. PMID: 39713200 Free PMC article. Review.

2

Genetically Engineered-Cell-Membrane Nanovesicles for Cancer Immunotherapy.

Cheng Q, Kang Y, Yao B, Dong J, Zhu Y, He Y, Ji X. Cheng Q, et al. Adv Sci (Weinh). 2023 Sep;10(26):e2302131. doi: 10.1002/advs.202302131. Epub 2023 Jul 6. Adv Sci (Weinh). 2023. PMID: 37409429 Free PMC article. Review.

3

Platelet-derived drug delivery systems: Pioneering treatment for cancer, cardiovascular diseases, infectious diseases, and beyond.

Zhu Y, Xu L, Kang Y, Cheng Q, He Y, Ji X. Zhu Y, et al. Among authors: cheng q. Biomaterials. 2024 Apr;306:122478. doi: 10.1016/j.biomaterials.2024.122478. Epub 2024 Jan 20. Biomaterials. 2024. PMID: 38266348 Review.

4

Magnetic nanoparticles coated with polyphenols for spatio-temporally controlled cancer photothermal/immunotherapy.

Zhang F, Lu G, Wen X, Li F, Ji X, Li Q, Wu M, Cheng Q, Yu Y, Tang J, Mei L. Zhang F, et al. Among authors: cheng q. J Control Release. 2020 Oct 10;326:131-139. doi: 10.1016/j.jconrel.2020.06.015. Epub 2020 Jun 21. J Control Release. 2020. PMID: 32580043

5

Engineered drug-loaded cellular membrane nanovesicles for efficient treatment of postsurgical cancer recurrence and metastasis.

Yu Y, Cheng Q, Ji X, Chen H, Zeng W, Zeng X, Zhao Y, Mei L. Yu Y, et al. Among authors: cheng q. Sci Adv. 2022 Dec 9;8(49):eadd3599. doi: 10.1126/sciadv.add3599. Epub 2022 Dec 9. Sci Adv. 2022. PMID: 36490349 Free PMC article.

6

Liposomes Encapsulating Neoantigens and Black Phosphorus Quantum Dots for Enhancing Photothermal Immunotherapy.

Zhang J, Chen X, Xue T, Cheng Q, Ye X, Wang C, Yu Y, Ji X, Wu M, Zhang X, Zheng Y, Wu B, Liang X, Mei L. Zhang J, et al. Among authors: cheng q. J Biomed Nanotechnol. 2020 Sep 1;16(9):1394-1405. doi: 10.1166/jbn.2020.2977. J Biomed Nanotechnol. 2020. PMID: 33419493

7

Adaptive Design of Nanovesicles Overcoming Immunotherapeutic Limitations of Chemotherapeutic Drugs through Poliovirus Receptor Blockade.

Yu Y, Zhang F, Xiao W, Cheng Q, Li T, Tang J, Tao W, Mei L. Yu Y, et al. Among authors: cheng q. ACS Nano. 2024 Feb 7. doi: 10.1021/acsnano.3c13056. Online ahead of print. ACS Nano. 2024. PMID: 38324591

8

3D Femtosecond Laser Beam Deflection for High-Precision Fabrication and Modulation of Individual Voxelated PCM Meta-Atoms.

Han W, Wei D, Peng B, Jiang J, Tong J, Xu Z, Zou X, Hu J, Cheng Q, Jiang L. Han W, et al. Among authors: cheng q. Adv Sci (Weinh). 2025 Jan 13:e2413316. doi: 10.1002/advs.202413316. Online ahead of print. Adv Sci (Weinh). 2025. PMID: 39806948

9

Discovery and exploration of adaptive immune response-related drug targets in diabetic retinopathy by Mendelian randomization.

Gao N, Li J, Wei T, Cheng Q, Gao S, Hu Y. Gao N, et al. Among authors: cheng q. Diabetes Res Clin Pract. 2025 Jan 11:111987. doi: 10.1016/j.diabres.2025.111987. Online ahead of print. Diabetes Res Clin Pract. 2025. PMID: 39805382

10

Evaluation of Plasma Neurodegenerative Biomarkers for Diagnosing Minimal Hepatic Encephalopathy and Predicting Overt Hepatic Encephalopathy in Chinese Patients with Hepatic Cirrhosis.

Cheng Q, Liu Y, Yang Z, Zhang M, Liu T, Niu Y, Liu W, Huang L, Feng Y, Zhang X, Luo X, Ning Q, Chen T. Cheng Q, et al. J Clin Transl Hepatol. 2025 Jan 28;13(1):35-46. doi: 10.14218/JCTH.2024.00413. Epub 2024 Dec 12. J Clin Transl Hepatol. 2025. PMID: 39801785 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,186 results

Search Page

Filters